Sa1200 REDUCED RISK OF BARRETT'S ESOPHAGUS WITH SGLT2 INHIBITORS/GLP1 RECEPTOR AGONISTS WHEN COMPARED TO METFORMIN ALONE: A NATIONAL DATABASE STUDY